JEREMIAH WILLIAMS: Open Payments
NPI 1750845343 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 23 payments from 10 companies in 2025. Trend: 2023 $1,858 · 2024 $937 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 6 | $104 |
| GENZYME CORPORATION | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| ALK-Abello, Inc | 1 | $17 |
| Organon LLC | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $14 |
Products named: DUPIXENT, NEFFY, FASENRA, CUVITRU, Grastek, VTAMA, Rhapsido, Ryaltris.
Industry payments across TX — which companies pay providers there.
